Appetitive Behavior — Weight Stigma Effect on Neural Control of Appetite
Citation(s)
Almeida L, Savoy S, Boxer P The role of weight stigmatization in cumulative risk for binge eating. J Clin Psychol. 2011 Mar;67(3):278-92. doi: 10.1002/jclp.20749. Epub 2010 Dec 3.
Araiza AM, Wellman JD Weight stigma predicts inhibitory control and food selection in response to the salience of weight discrimination. Appetite. 2017 Jul 1;114:382-390. doi: 10.1016/j.appet.2017.04.009. Epub 2017 Apr 14.
Dagher A Functional brain imaging of appetite. Trends Endocrinol Metab. 2012 May;23(5):250-60. doi: 10.1016/j.tem.2012.02.009. Epub 2012 Apr 5. Review.
Hunger JM, Major B, Blodorn A, Miller CT Weighed down by stigma: How weight-based social identity threat contributes to weight gain and poor health. Soc Personal Psychol Compass. 2015 Jun;9(6):255-268. doi: 10.1111/spc3.12172. Epub 2015 Jun 4.
Levy BR, Pilver CE Residual stigma: psychological distress among the formerly overweight. Soc Sci Med. 2012 Jul;75(2):297-9. doi: 10.1016/j.socscimed.2012.03.007. Epub 2012 Apr 3.
Vartanian LR, Porter AM Weight stigma and eating behavior: A review of the literature. Appetite. 2016 Jul 1;102:3-14. doi: 10.1016/j.appet.2016.01.034. Epub 2016 Jan 29. Review.
Wellman JD, Araiza AM, Newell EE, McCoy SK Weight stigma facilitates unhealthy eating and weight gain via fear of fat. Stigma Health. 2018 Aug;3(3):186-194. doi: 10.1037/sah0000088. Epub 2017 Feb 9.
Wott CB, Carels RA Overt weight stigma, psychological distress and weight loss treatment outcomes. J Health Psychol. 2010 May;15(4):608-14. doi: 10.1177/1359105309355339.
Wu YK, Berry DC Impact of weight stigma on physiological and psychological health outcomes for overweight and obese adults: A systematic review. J Adv Nurs. 2018 May;74(5):1030-1042. doi: 10.1111/jan.13511. Epub 2017 Dec 8. Review.
Exposure to Weight Stigmatization Content: Neural Correlations With Appetite Control, Social Support, Mood and Weight Stigma Experiences
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
